Purchase Order 75N91020P00169
Award Date 2/19/20
Potential Completion Date 2/23/21
Potential Value $19K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02115, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a purchase order to Brigham & Women's Hospital Inc., Department of Faulkner Pathology, for $10,829.00 on June 3, 2013, with final completion on June 2, 2014. The order is firm fixed price with no set-aside. Performance occurs in Boston, Massachusetts. The work involves aliquotting plasma samples from the Health Professionals Follow-Up Study and Nurses' Health Study to support a pooled investigation of adiponectin and multiple myeloma in the NCI Cohort...
- <p>The National Cancer Institute issued a purchase order to Brigham & Women's Hospital Inc., doing business as Department Of Faulkner Pathology, for $23,450 in ovarian cancer tissue blocks, awarded September 18, 2017, with completion by December 6, 2017. Work is performed in Boston, Massachusetts. The order is firm fixed price with no set-aside.</p>
- The National Cancer Institute awarded a purchase order to Dana-Farber Cancer Institute, Inc. for germline DNA samples and data from renal cell carcinoma patients supporting the National Cancer Institute's Renal Cell Carcinoma Genome-Wide Association Study, with a ceiling value of $18,000.00 and an award date of April 10, 2019. Work is performed in Boston, Massachusetts under firm fixed-price terms, with ultimate completion on April 9, 2020. The purchase order procures biological specimens and...
- <p>The National Cancer Institute issued a purchase order to The Children's Hospital Corporation (doing business as Boston Children's Hospital) for $14,846.00 in professional services, awarded August 28, 2019, with completion by August 31, 2020. Work is performed at Bethesda, Maryland. Pricing is firm fixed price.</p>
- <p>The National Cancer Institute awarded a purchase order to The Children's Hospital Corporation (doing business as Boston Children's Hospital) valued at $14,964.00 on September 17, 2018, with a firm fixed price structure and ultimate completion date of October 1, 2019. Place of performance is Bethesda, Maryland. The order carries no set-aside designation.</p>
- <p>The National Cancer Institute issued a delivery order to Boston Medical Center Corporation on August 23, 2016, under the Tissue Source Site for Tumor Analysis IDIQ with a ceiling value of $15,589.93.</p> <p>Place of performance is Roxbury, MA. The order supports CPTAC (Clinical Proteomic Tumor Analysis Consortium) imaging task order activities. Ultimate completion date is August 22, 2018. The order is firm fixed price with no set-aside.</p>
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services, to Brigham & Women's Hospital, Inc. The $143,587.50 contract supports the Cancer Genome Atlas (TCGA) program's effort to collect tissue samples and data from various types of cancer. The award is funded through the American Recovery and Reinvestment Act (ARRA) and does not have a small business set-aside designation. Brigham & Women's...
- <p>The National Cancer Institute awarded a purchase order to Trustees of Boston University for $24,840 on September 15, 2017. The order, a firm fixed price acquisition with no set-aside, is for work to be performed in Rockville, Maryland, with an ultimate completion date of September 21, 2018.</p>
- <p>The National Cancer Institute awarded a purchase order to the President and Fellows of Harvard College (Harvard University) valued at $60,080 on September 18, 2017, for expanded analyses of circulating vitamin D and risk of colorectal and breast cancer by cancer subtypes and in population subgroups. The order carries firm fixed price, no set-aside, and ultimate completion is September 17, 2018. Place of performance is Bethesda, Maryland.</p>
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Brigham & Women's Hospital Inc. valued at $12,096.00 on August 6, 2019. The order carries no set-aside designation and is priced on a firm fixed-price basis. Work is performed at Rockville, Maryland. The ultimate completion date is December 27, 2019.</p>